GenIC Request Template

GenIC Request.pdf

[OADPS] The Performance Measures Project: Improving Performance Measurement and Monitoring by CDC Programs

GenIC Request Template

OMB: 0920-1282

Document [pdf]
Download: pdf | pdf
OMB Control Number 0920-1282
Performance Measures Project
Request for GenIC Approval (for data collection in 2023, 2024, 2025)
CIO: NCHHSTP/DSTDP/PDEB
PROJECT TITLE: Enhancing STI and Sexual Health Clinic Infrastructure (ESSHCI)
PURPOSE AND USE OF COLLECTION: Performance measurement and evaluation - The
Enhancing STI and Sexual Health Clinical Infrastructure (ESSHCI) serves to strengthen clinic
infrastructure and expand access to comprehensive sexual health services in high burden and
underserved areas. ESSHCI supports clinics to, 1) foster community engagement and strategic
partnerships to support expansion of sexual health services, 2) strengthen clinic infrastructure and
provision of sexual health services, and 3) conduct short-term activities to expand access to STI
prevention and other sexual health services supporting a syndemic approach.
Project outcomes include increased community involvement in clinic-level planning, increased
engagement with public health partners, increased access to & capacity to provide comprehensive
sexual health services, improved patient clinic experience, increased identification of new STIs, and
increased linkage to prevention and care services for co-occurring conditions.
CDC will use performance measures for PS23-0011 to monitor and evaluate the outcomes of this
project. The performance measures associated with this cooperative agreement are intended to be
used by CDC and recipients to: Monitor implementation and progress toward achieving intended
outcomes, demonstrate accountability to interested parties (e.g., funders, public) by showing how
funds are being spent, maximize learning opportunities and technical assistance needs associated
with the implementation, and assess the impact of this cooperative agreement to strengthen clinic
infrastructure and expand access to comprehensive sexual health services.
NUMBER AND TITLE OF NOFO: CDC-RFA-PS-23-0011 Enhancing STI and Sexual Health Clinic
Infrastructure (ESSHCI)
NUMBER OF PARTICIPATING RECIPIENTS: 26 recipients representing state health departments,
academic institutions, and non-governmental organizations.
DESCRIPTION OF NOFO (check all that apply):
__

Funds all 50 states

__

Has budget higher than $10 million per year

_X_

Has significant stakeholder interest (e.g. partners, Congress)

Please elaborate:
Through RFA PS-23-0011 CDC awarded a total of $5,000,000 over a 5-year period to 26 recipients
(Attachment 1- List of funded ESSHCI recipients) to implement strategies to strengthen clinic
infrastructure and expand access to comprehensive sexual health services. This cooperative

agreement includes the implementation of two required strategies A & B, and an optional strategy C.
Strategy A (required strategy for year 1) will foster community engagement and strategic
partnerships to support expansion of sexual health services. The associated activities under this
strategy include: engage priority populations disproportionately impacted by STIs, mobilize public
health partners, and develop a plan to increase access to quality comprehensive sexual health
services. Strategy B (required strategy for years 1 – 5) will strengthen clinic infrastructure and
provision of comprehensive sexual health services. Associated activities include: conduct clinic
infrastructure assessment, implement a plan to increase access to sexual health services, enhance
clinic sexual health services, and assess and improve the patient clinic experience. Strategy C
(optional strategy for years 1 – 5) will fund a subset of proposed short-term activities each budget
period to expand access to STI prevention and other sexual health services supporting a syndemic
approach. The ESSCHI NOFO outcomes include increased community involvement in clinic-level
planning, increased engagement with public health partners, increased access to & capacity to
provide comprehensive sexual health services, improved patient clinic experience, increased
identification of new STIs, and increased linkage to prevention and care services for co-occurring
conditions. To address inequities and gaps in sexual health services, this cooperative agreement will
prioritize communities with high STI burden and unmet need for STI clinical services.
As this cooperative agreement represents new funding to strengthen sexual health clinic
infrastructure, many stakeholders within the recipients’ respective communities, CDC, and HHS at
large are invested and interested in the program and its outcomes to enhance STI and sexual health
clinic infrastructure.
PERFORMANCE METRICS USED & JUSTIFICATIONS:
The performance measures for the ESSCHI NOFO are purposed to demonstrate the achievement of
program outcomes, build a stronger evidence base for specific program strategies, clarify the
applicability of the evidence base to different populations, settings, and contexts, and drive
continuous program improvement. Minimizing the burden of performance measures reporting was
an active consideration throughout the process of identifying performance measures for this
cooperative agreement. Each measure is drafted to ensure relevance with the program strategies
and outcomes (Attachment 2- Technical Specifications)
For required strategy A (Foster community engagement and partnerships), a total of 5 performance
measures of qualitative and quantitative variables are required to be reported by all recipients to
assess community involvement in clinic-level planning for provision of comprehensive sexual health
services (outcome 1) and engagement with public health partners addressing the STI epidemic
(outcome 2) (Attachment 3a- Data Reporting Template). For required strategy B (Strengthen clinic
infrastructure and provision of comprehensive sexual health services), a total of 13 performance
measures of qualitative and quantitative variables are required to be reported by all recipients to
assess: clinics’ capacity to provide quality comprehensive sexual health services (outcome 1);
patients’ clinic experience (outcome 2); identification of new STIs by clinic (outcome 3); and linkage
to public health partners for prevention and care services for co-occurring conditions (outcome 4)
(Attachment 3a- Data Reporting Template). The 13 measures include summary of the
standardized Quality STD Clinical Services (QCS) assessment (Attachment 3b- STD QCSAssessment-Tool) which recipients are required to complete as part of their implementation
activities and report to assess their clinic capacity to provide quality comprehensive sexual health
1

services (outcome 1). Where appropriate, for performance measures assessing outcomes 3 and 4,
the aggregated data will be reported stratified by the variables age, gender, race and ethnicity,
gender of sex partners, population group, and insurance status (Attachment 3a- Data Reporting
Template). Race and ethnicity are to be collected at the local level in accordance with OMB
standards. Hispanic or Latino persons can be of any race. Strategy C is optional and performance
measures will be reported only by clinics funded to implement the strategy. For strategy C, 3
performance measures of qualitative variables are required (of select recipients) to assess access to
quality, stigma-free STI care and comprehensive sexual health services, especially among priority
populations affected by STIs (outcome 1) (Attachment 3a - Data Reporting Template).
All measures will be reported in aggregate to CDC by recipients, twice a year using the data
reporting templates provided by the CDC evaluation team (Attachment 3a- Data Reporting
Template and Attachment 3b- STD QCS-Assessment-Tool). Biannual data reporting is necessary
for CDC to continue to identify program performance issues that might result in costly program
inefficiencies and provide timely assistance to recipients.
This Generic IC request matches the intent of this ICR by being directly related to performance
measurement for CDC cooperative agreements, to cover twice yearly submission of select,
aggregate data points from recipients to CDC for performance measurement purposes (Attachment
4-Recipient Email). In this way, the data collection templates are fully in alignment with this Generic
IC, in terms of the intent, format, type, and level of data to be collected.
CERTIFICATION:
I certify the following to be true:
1. The collection is non-controversial and does not raise issues of concern to other federal
agencies.
2. Information gathered is meant primarily for program improvement and accountability; it is not
intended to be used as the principal basis for policy decisions.
Name: __ Shaunta S. Wright /Shaunta S. Wright________________________________
To assist review, please answer the following questions:

ANNUALIZED BURDEN HOURS:
This table calculates the total estimated burden per year for all recipients.
Type of
Respondent

Form Name

State/Local
Government

STD QCS
Assessment tool

No. of
Respondents

No. of
Responses
per
Respondent

Avg.
Burden Per
Response

Total
Annualized
Burden
Hours

6

2

6

72

2

State/Local
Government

ESSHCI PMP
Reporting template

6

2

40

480

Private Institutions

STD QCS
Assessment tool

2

2

6

24

Private Institutions

ESSHCI PMP
Reporting template

2

2

40

160

Non-governmental
Organizations

STD QCS
Assessment tool

18

2

6

216

Non-governmental
Organizations

ESSHCI PMP
Reporting template

18

2

40

1440

138

2,392

Totals

26

TOTAL BURDEN HOURS FOR THIS GENIC:
This table specifies the calendar years in which information will be collected and calculates the total
burden hours requested over the approved timeframe of the generic.
Data Collection Timeframe (List up to 3
Years)

No. Years
Requested

2024, 2025, 2026

3

Annualized
Burden Hours

2,392

Total Burden Hours
for this GENIC

7,176

See examples provided with this template.
FEDERAL COST: The estimated annual cost to the Federal government is ___$318,888___
The cost is based on providing technical assistance to jurisdictions on the Data Collection Tools and
review, analysis, and reporting of the submitted data by three personnel: one GS-12, Step 1 staff at
annual salary $87,466; one GS-12, Step 4 staff at annual salary $96,213; and one GS-13, Step 10
staff at annual salary $135,209 SALARY TABLE 2023-ATL (opm.gov). Total: $87,466 + $96,213 +
$135,209 = $318,888

ADMINISTRATION OF THE INSTRUMENT:
1. How will you collect the information? (Check all that apply)
[ ] Web-based
[ ] Email
[ ] Postal Mail
[ X ] Other, Explain: Other, CDC’s Secure Access Management System is used for the
submission of data.
3


File Typeapplication/pdf
File TitleDOCUMENTATION FOR THE GENERIC CLEARANCE
Author558022
File Modified2024:02:02 08:38:29-05:00
File Created2024:02:02 08:38:28-05:00

© 2024 OMB.report | Privacy Policy